Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-25-010179

Options or other derivatives

  • Director acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DELUCCIA ROBERT J Director 2025-02-05 Grant or award · Stock Option +250,000 250,000 D
Loading xslF345X05/tm255798-1_4seq1.xml…